Xi'an International Medical Investment Company Limited

000516.SZ

000516.SZXi'an International Medical Investment Company Limited

Shenzhen

4.23

CNY

-0.22

(-4.94%)

-0.14EPS

-30.21P/E

9.45BMarket Cap

May 20Next Earn

Upgrade to Unlock Non-US CompaniesTo view real-time data and analysis of companies outside of the United States, upgrade your account to our premium subscription.

Upgrade

Xi'an International Medical Investment Company Limited

000516.SZ

(Shenzhen)

Recent

price

4.23

P/E

ratio

-30.21

div

yld

- -

ROIC.AI

Legends:

Stock price

Beta (1.0 Market)

% total return 09/15

Stock

S&P500

-46.86

26.76

-57.32

25.48

-15.74

87.24

2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	TTM
2.91	3.02	1.39	1.91	1.96	2	2.17	5.18	1.95	2.09	1.04	0.52	0.71	1.31	1.2	2.01	2.14	Revenue per Share
0.08	0.1	0.08	0.07	0.06	0.07	0.2	0.32	0.1	0.1	1.11	-0.21	0.02	-0.37	-0.52	-0.16	-0.14	Basic EPS, GAAP
-0.07	-0.04	0.1	0.2	0.21	0.07	0.11	-0.11	0.11	-0.27	-1.26	-1.9	-0.57	-0.54	-0.32	0.14	-0.31	Free Cash Flow per Basic Share
0.06	0.08	0.03	0.03	0.06	0.06	0.05	0.07	0.04	0.05	0.01	0.14	0.09	0.1	0.11	0.09	0.1	Dividend per Share
0.58	0.78	0.48	0.56	0.6	0.63	0.79	2.28	1.51	1.63	2.61	2.37	2.03	1.84	1.29	1.1	1.04	Book Value per Share
0.83	1.08	0.53	0.5	0.56	0.55	0.73	3.73	1.48	1.59	2.68	2.28	1.92	2.09	1.54	1.33	1.24	Tangible Book Value per Share
703	768	1,812	1,767	1,735	1,787	1,787	753	2,016	1,945	1,968	1,923	2,268	2,222	2,263	2,302	2,261	Basic Weighted Avg Shares
2,041	2,319	2,526	3,378	3,403	3,566	3,883	3,900	3,931	4,060	2,039	991	1,607	2,921	2,711	4,618	4,829	Sales/Revenue/Turnover
5.97	6.22	6.94	6.58	6.24	6.92	9.11	7.81	7.72	7.1	5.21	-28.33	-36.86	-22.58	-32.28	-6.51	-4.58	Operating Margin (%)
43	41	62	81	117	116	107	106	116	120	82	121	376	569	620	770	- -	Depreciation Expense
59	77	152	127	111	122	350	241	202	195	2,184	-404	45	-822	-1,177	-368	-320	Net Income, GAAP
26.41	29.13	26.16	30.9	30.61	24.25	20	23.77	24.4	26.56	26.43	- -	- -	- -	- -	- -	- -	Effective Tax Rate (%)
2.9	3.31	6.03	3.77	3.26	3.41	9.02	6.18	5.13	4.79	107.11	-40.76	2.82	-28.15	-43.4	-7.98	-6.62	Profit Margin (%)
-104	-436	-103	-955	-957	-886	-416	825	866	-50	1,400	-245	-803	-1,165	-1,817	-2,203	-2,354	Working Capital
183	199	308	157	85	70	124	175	100	130	571	3,155	3,906	4,452	3,474	3,376	3,284	LT Debt
703	944	1,069	1,118	1,193	1,283	1,597	3,328	3,499	3,717	5,797	4,996	5,033	5,331	4,251	3,816	3,542	Total Equity
7.25	6.68	7.2	7.85	7.22	9.08	12.17	6.69	5.13	4.56	1.39	- -	- -	- -	- -	- -	- -	Return on Invested Capital (%)
7.01	5.99	11.95	8.99	8.55	9.23	18.68	11.07	6.91	5.54	42.41	- -	- -	- -	- -	- -	- -	Return on Capital (%)
15.75	15.26	20.73	13.74	10.95	11.2	27.56	15.4	8.47	6.26	52.59	-8.32	0.99	-18.88	-33.56	-13.51	-12.68	Return on Common Equity (%)

Capital Structure

•

in mil. unless spec.

Working Capital

•

in mil. unless spec.

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)	10 years	5 years	1 year
Sales/Revenue/Turnover	11.93%	31.14%	70.34%
Net Income, GAAP	-100.78%	-433.56%	-68.69%
Free Cash Flow	-60.5%	-41.67%	-144.69%
Total Cash Common Dividend	100.08%	208.62%	-11.42%
Total Equity	16.26%	-7.53%	-10.23%

Growth Rates

•

in mil. unless spec.

Quarterly Revenue

•

in mil. unless spec.

Quarterly Earnings Per Share

•

in mil. unless spec.

Quarterly Dividends Per Share

•

in mil. unless spec.

Business: Xi'an International Medical Investment Company Limited provides medical services. It operates hospitals and medical centers. The company was formerly known as Xi'an Kaiyuan Investment Group Co., Ltd. and changed its name to Xi'an International Medical Investment Company Limited in January 2015. The company was founded in 1956 and is based in Xi'an, China.

2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	TTM
2.91	3.02	1.39	1.91	1.96	2	2.17	5.18	1.95	2.09	1.04	0.52	0.71	1.31	1.2	2.01	2.14	Revenue per Share
0.08	0.1	0.08	0.07	0.06	0.07	0.2	0.32	0.1	0.1	1.11	-0.21	0.02	-0.37	-0.52	-0.16	-0.14	Basic EPS, GAAP
-0.07	-0.04	0.1	0.2	0.21	0.07	0.11	-0.11	0.11	-0.27	-1.26	-1.9	-0.57	-0.54	-0.32	0.14	-0.31	Free Cash Flow per Basic Share
0.06	0.08	0.03	0.03	0.06	0.06	0.05	0.07	0.04	0.05	0.01	0.14	0.09	0.1	0.11	0.09	0.1	Dividend per Share
0.58	0.78	0.48	0.56	0.6	0.63	0.79	2.28	1.51	1.63	2.61	2.37	2.03	1.84	1.29	1.1	1.04	Book Value per Share
0.83	1.08	0.53	0.5	0.56	0.55	0.73	3.73	1.48	1.59	2.68	2.28	1.92	2.09	1.54	1.33	1.24	Tangible Book Value per Share
703	768	1,812	1,767	1,735	1,787	1,787	753	2,016	1,945	1,968	1,923	2,268	2,222	2,263	2,302	2,261	Basic Weighted Avg Shares
2,041	2,319	2,526	3,378	3,403	3,566	3,883	3,900	3,931	4,060	2,039	991	1,607	2,921	2,711	4,618	4,829	Sales/Revenue/Turnover
5.97	6.22	6.94	6.58	6.24	6.92	9.11	7.81	7.72	7.1	5.21	-28.33	-36.86	-22.58	-32.28	-6.51	-4.58	Operating Margin (%)
43	41	62	81	117	116	107	106	116	120	82	121	376	569	620	770	- -	Depreciation Expense
59	77	152	127	111	122	350	241	202	195	2,184	-404	45	-822	-1,177	-368	-320	Net Income, GAAP
26.41	29.13	26.16	30.9	30.61	24.25	20	23.77	24.4	26.56	26.43	- -	- -	- -	- -	- -	- -	Effective Tax Rate (%)
2.9	3.31	6.03	3.77	3.26	3.41	9.02	6.18	5.13	4.79	107.11	-40.76	2.82	-28.15	-43.4	-7.98	-6.62	Profit Margin (%)
-104	-436	-103	-955	-957	-886	-416	825	866	-50	1,400	-245	-803	-1,165	-1,817	-2,203	-2,354	Working Capital
183	199	308	157	85	70	124	175	100	130	571	3,155	3,906	4,452	3,474	3,376	3,284	LT Debt
703	944	1,069	1,118	1,193	1,283	1,597	3,328	3,499	3,717	5,797	4,996	5,033	5,331	4,251	3,816	3,542	Total Equity
7.25	6.68	7.2	7.85	7.22	9.08	12.17	6.69	5.13	4.56	1.39	- -	- -	- -	- -	- -	- -	Return on Invested Capital (%)
7.01	5.99	11.95	8.99	8.55	9.23	18.68	11.07	6.91	5.54	42.41	- -	- -	- -	- -	- -	- -	Return on Capital (%)
15.75	15.26	20.73	13.74	10.95	11.2	27.56	15.4	8.47	6.26	52.59	-8.32	0.99	-18.88	-33.56	-13.51	-12.68	Return on Common Equity (%)

	Dec'23	Mar'24	Jun'24
ST Debt	1,299	1,187	1,316
LT Borrowings	3,376	3,373	3,284
LT Finance Leases	- -	- -	- -
Preferred Equity and Hybrid Capital	- -	- -	- -
Shares Outstanding	2,261	2,261	2,261
Market Capitalization	18,480	14,041	10,582

	Dec'23	Mar'24	Jun'24
Total Current Assets	1,913	1,636	1,554
Accounts Receivable, Net	662	647	658
Cash, Cash Equivalents & STI	1,080	808	715
Inventories	78	76	74
Total Current Liabilities	4,116	3,835	3,908
Payables & Accruals	- -	- -	- -
ST Debt	1,299	1,187	1,316
Deferred Revenue	- -	- -	- -

Year	Q1	Q2	Q3	Q4	FY
2022	305	763	846	797	2,711
2023	1,059	1,151	1,134	1,274	4,618
2024	1,173	1,248	- -	- -	- -

Year	Q1	Q2	Q3	Q4	FY
2022	-0.19	- -	- -	- -	-0.52
2023	-0.03	- -	- -	- -	-0.16
2024	-0.05	- -	- -	- -	- -

Xi'an International Medical Investment Company Limited

Growth Rates

(avg. rate of change)

Growth Rates

(avg. rate of change)

Capital Structure

Working Capital

Quarterly Earnings Per Share

Year

Quarterly Revenue

Year

Quarterly Dividends Per Share

Year